REAL

Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates

Zwick, V. and Nurisso, A. and Simões-Pires, C. and Bouchet, S. and Martinet, N. and Lehotzky, Attila and Ovádi, Judit (2016) Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 26 (1). pp. 154-159. ISSN 0960-894X

[img] Text
Zwick_et_al_2015_Bioorg_medChem_u.pdf
Restricted to Repository staff only

Download (1MB) | Request a copy
Item Type: Article
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat > RC0254 Neoplasms. Tumors. Oncology (including Cancer) / daganatok, tumorok, onkológia
SWORD Depositor: MTMT SWORD
Depositing User: MTMT SWORD
Date Deposited: 13 Apr 2016 07:03
Last Modified: 13 Apr 2016 07:03
URI: http://real.mtak.hu/id/eprint/34688

Actions (login required)

Edit Item Edit Item